Calamos Advisors LLC Acquires 43,439 Shares of Waters Corporation $WAT

Waters logo with Healthcare background
Image from MarketBeat Media, LLC.

Key Points

  • Calamos Advisors increased its Waters stake by 43,439 shares in the third quarter, a 548.9% boost, bringing its holdings to 51,353 shares valued at about $22.6 million.
  • Waters reported quarterly EPS of $4.10, beating estimates of $4.00, and revenue of $1.77 billion, ahead of forecasts and up 120.9% year over year.
  • Analyst sentiment was broadly positive: the stock had a “Moderate Buy” consensus rating and an average price target of $475.48.
  • Five stocks to consider instead of Waters.

Calamos Advisors LLC boosted its holdings in shares of Waters Corporation (NYSE:WAT - Free Report) by 548.9% during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 51,353 shares of the medical instruments supplier's stock after buying an additional 43,439 shares during the quarter. Calamos Advisors LLC owned 0.05% of Waters worth $22,564,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in WAT. Pilgrim Global Advisors LLC purchased a new stake in shares of Waters during the second quarter worth $466,131,171,000. BlackRock Inc. acquired a new stake in shares of Waters in the second quarter valued at $3,182,191,000. Jupiter Topco LLC acquired a new stake in shares of Waters in the second quarter valued at $623,921,000. Wellington Management Group LLP raised its stake in shares of Waters by 69.2% in the second quarter. Wellington Management Group LLP now owns 1,373,150 shares of the medical instruments supplier's stock valued at $514,986,000 after acquiring an additional 561,824 shares in the last quarter. Finally, Bank of New York Mellon Corp purchased a new position in Waters in the second quarter valued at $188,725,000. Hedge funds and other institutional investors own 94.01% of the company's stock.

Wall Street Analysts Forecast Growth

Several research analysts recently commented on the company. Guggenheim boosted their target price on Waters from $440.00 to $490.00 and gave the stock a "buy" rating in a research note on Thursday, October 1st. Morgan Stanley set a $430.00 price target on Waters in a report on Wednesday, August 5th. The Goldman Sachs Group increased their price target on Waters from $465.00 to $515.00 and gave the company a "buy" rating in a research report on Monday, September 21st. TD Cowen lifted their price objective on Waters from $515.00 to $530.00 and gave the company a "buy" rating in a research note on Wednesday. Finally, HSBC lifted their price objective on Waters from $450.00 to $455.00 and gave the company a "buy" rating in a research note on Tuesday, September 1st. One investment analyst has rated the stock with a Strong Buy rating, seventeen have given a Buy rating and six have given a Hold rating to the company. According to MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and an average price target of $475.48.

View Our Latest Analysis on WAT

Waters Trading Up 1.1%

Shares of NYSE:WAT opened at $457.92 on Friday. Waters Corporation has a 52 week low of $282.77 and a 52 week high of $482.28. The company's 50 day moving average is $434.72 and its two-hundred day moving average is $372.24. The company has a market cap of $44.99 billion, a PE ratio of 196.53, a P/E/G ratio of 2.60 and a beta of 1.16. The company has a current ratio of 0.66, a quick ratio of 1.29 and a debt-to-equity ratio of 0.32.

Waters (NYSE:WAT - Get Free Report) last released its quarterly earnings data on Tuesday, November 3rd. The medical instruments supplier reported $4.10 earnings per share (EPS) for the quarter, topping the consensus estimate of $4.00 by $0.10. The business had revenue of $1.77 billion during the quarter, compared to analysts' expectations of $1.75 billion. Waters had a net margin of 1.75% and a return on equity of 9.91%. The company's revenue for the quarter was up 120.9% on a year-over-year basis. During the same period in the previous year, the company earned $3.40 EPS. Equities analysts predict that Waters Corporation will post 14.65 earnings per share for the current fiscal year.

Waters News Roundup

Here are the key news stories impacting Waters this week:

About Waters

(Free Report)

Waters Corporation develops and supplies analytical instruments, software, and consumables used to identify, measure, and characterize chemical and biological materials. Its products include liquid chromatography and mass spectrometry systems, which help customers analyze complex samples.

The company serves pharmaceutical and biotechnology businesses, academic and government laboratories, and customers in fields such as food, environmental testing, and materials science. Waters operates internationally, with customers and operations across multiple regions.

Founded in 1958 by James L.

See Also

Institutional Ownership by Quarter for Waters (NYSE:WAT)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Waters Right Now?

Before you consider Waters, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Waters wasn't on the list.

While Waters currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Don't Wait for the OpenAI IPO Cover

The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines